570 related articles for article (PubMed ID: 36142794)
1. Recent Advances in the Emerging Therapeutic Strategies for Diabetic Kidney Diseases.
Huang W; Chen YY; Li ZQ; He FF; Zhang C
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142794
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets.
Barrera-Chimal J; Jaisser F
Diabetes Obes Metab; 2020 Apr; 22 Suppl 1():16-31. PubMed ID: 32267077
[TBL] [Abstract][Full Text] [Related]
3. What's New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances.
Watanabe K; Sato E; Mishima E; Miyazaki M; Tanaka T
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614011
[TBL] [Abstract][Full Text] [Related]
4. A Narrative Review of Diabetic Kidney Disease: Previous and Current Evidence-Based Therapeutic Approaches.
Mima A
Adv Ther; 2022 Aug; 39(8):3488-3500. PubMed ID: 35751762
[TBL] [Abstract][Full Text] [Related]
5. Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.
Mazzieri A; Porcellati F; Timio F; Reboldi G
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612779
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the pharmacotherapeutic management of diabetic kidney disease.
Block TJ; Batu D; Cooper ME
Expert Opin Pharmacother; 2022 May; 23(7):791-803. PubMed ID: 35522659
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress as a culprit in diabetic kidney disease.
Su S; Ma Z; Wu H; Xu Z; Yi H
Life Sci; 2023 Jun; 322():121661. PubMed ID: 37028547
[TBL] [Abstract][Full Text] [Related]
8. SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease.
Zou H; Zhou B; Xu G
Cardiovasc Diabetol; 2017 May; 16(1):65. PubMed ID: 28511711
[TBL] [Abstract][Full Text] [Related]
9. Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease.
Yang Y; Xu G
Front Endocrinol (Lausanne); 2022; 13():872918. PubMed ID: 35663316
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Diabetic Kidney Disease: Current and Future.
Yamazaki T; Mimura I; Tanaka T; Nangaku M
Diabetes Metab J; 2021 Jan; 45(1):11-26. PubMed ID: 33508907
[TBL] [Abstract][Full Text] [Related]
11. Potential of Renin-Angiotensin-Aldosterone System Modulations in Diabetic Kidney Disease: Old Players to New Hope!
Malek V; Suryavanshi SV; Sharma N; Kulkarni YA; Mulay SR; Gaikwad AB
Rev Physiol Biochem Pharmacol; 2021; 179():31-71. PubMed ID: 32979084
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Targeting of SGLT2: A New Era in the Treatment of Diabetes and Diabetic Kidney Disease.
Shaffner J; Chen B; Malhotra DK; Dworkin LD; Gong R
Front Endocrinol (Lausanne); 2021; 12():749010. PubMed ID: 34790170
[TBL] [Abstract][Full Text] [Related]
13. SGLT2 Inhibitors and Other Novel Therapeutics in the Management of Diabetic Kidney Disease.
Stanton RC
Semin Nephrol; 2021 Mar; 41(2):85-95. PubMed ID: 34140099
[TBL] [Abstract][Full Text] [Related]
14. Diabetic Kidney Disease Back in Focus: Management Field Guide for Health Care Professionals in the 21st Century.
Alicic R; Nicholas SB
Mayo Clin Proc; 2022 Oct; 97(10):1904-1919. PubMed ID: 36202498
[TBL] [Abstract][Full Text] [Related]
15. Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms.
Xu C; Ha X; Yang S; Tian X; Jiang H
Front Endocrinol (Lausanne); 2023; 14():1232790. PubMed ID: 37859992
[TBL] [Abstract][Full Text] [Related]
16. New progress in drugs treatment of diabetic kidney disease.
Wang J; Xiang H; Lu Y; Wu T; Ji G
Biomed Pharmacother; 2021 Sep; 141():111918. PubMed ID: 34328095
[TBL] [Abstract][Full Text] [Related]
17. Targeting Inflammation in Diabetic Kidney Disease: Is There a Role for Pentoxifylline?
Leehey DJ
Kidney360; 2020 Apr; 1(4):292-299. PubMed ID: 35372914
[TBL] [Abstract][Full Text] [Related]
18. The future of diabetic kidney disease management: what to expect from the experimental studies?
Barutta F; Bellini S; Corbetta B; Durazzo M; Gruden G
J Nephrol; 2020 Dec; 33(6):1151-1161. PubMed ID: 32221858
[TBL] [Abstract][Full Text] [Related]
19. Update on diagnosis, pathophysiology, and management of diabetic kidney disease.
Sugahara M; Pak WLW; Tanaka T; Tang SCW; Nangaku M
Nephrology (Carlton); 2021 Jun; 26(6):491-500. PubMed ID: 33550672
[TBL] [Abstract][Full Text] [Related]
20. Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies.
Warren AM; Knudsen ST; Cooper ME
Expert Opin Ther Targets; 2019 Jul; 23(7):579-591. PubMed ID: 31154867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
